Shanxi C&Y Pharmaceutical Group Co Ltd Total Assets
Shanxi C&Y Pharmaceutical Group Co Ltd total assets. Based on the latest financial reports, Shanxi C&Y Pharmaceutical Group Co Ltd (300254) holds total assets worth CN¥1.53 Billion CNY (≈ $223.70 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Shanxi C&Y Pharmaceutical Group Co Ltd (300254) total market value for the company's overall valuation and market capitalisation.
Total Assets of Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)
Total assets of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025. This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's total assets have evolved over time, based on quarterly financial data. See 300254 stock price for real-time trading data and today's change.
Shanxi C&Y Pharmaceutical Group Co Ltd - Asset Composition Analysis
Shanxi C&Y Pharmaceutical Group Co Ltd Total Assets Breakdown (December 2025)
Shanxi C&Y Pharmaceutical Group Co Ltd total assets breakdown as of December 2025. Shanxi C&Y Pharmaceutical Group Co Ltd's total assets of CN¥1.53 Billion consist of 36.8% current assets and 63.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 9.8% |
| Accounts Receivable | CN¥207.28 Million | 12.6% |
| Inventory | CN¥132.91 Million | 8.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥204.46 Million | 12.5% |
| Goodwill | CN¥311.99 Million | 19.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Shanxi C&Y Pharmaceutical Group Co Ltd current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanxi C&Y Pharmaceutical Group Co Ltd's current assets represent 36.8% of total assets in 2025, a decrease from 55.0% in 2008.
- Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, up from 2.8% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 11.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 19.0% of total assets.
Shanxi C&Y Pharmaceutical Group Co Ltd Competitors by Total Assets
Key competitors of Shanxi C&Y Pharmaceutical Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF22.86 Billion |
|
H Lundbeck A/S
CO:HLUN-B
|
Denmark | Dkr54.01 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Viyash Scientific Limited
NSE:SEQUENT
|
India | Rs17.26 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥5.11 Billion |
Shanxi C&Y Pharmaceutical Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 0.94 | 1.08 |
| Quick Ratio | 0.66 | 0.63 | 0.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.51 Million | CN¥-30.57 Million | CN¥33.54 Million |
Shanxi C&Y Pharmaceutical Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shanxi C&Y Pharmaceutical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.83 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 6.1% |
| Total Assets | CN¥1.64 Billion |
| Market Capitalization | $283.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanxi C&Y Pharmaceutical Group Co Ltd's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shanxi C&Y Pharmaceutical Group Co Ltd's assets grew by 6.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)
The table below shows the annual total assets of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.64 Billion ≈ $240.36 Million |
+6.13% |
| 2024-12-31 | CN¥1.55 Billion ≈ $226.48 Million |
+8.00% |
| 2023-12-31 | CN¥1.43 Billion ≈ $209.70 Million |
-9.55% |
| 2022-12-31 | CN¥1.58 Billion ≈ $231.84 Million |
+3.77% |
| 2021-12-31 | CN¥1.53 Billion ≈ $223.42 Million |
-15.20% |
| 2020-12-31 | CN¥1.80 Billion ≈ $263.47 Million |
-0.08% |
| 2019-12-31 | CN¥1.80 Billion ≈ $263.69 Million |
+20.48% |
| 2018-12-31 | CN¥1.50 Billion ≈ $218.87 Million |
-1.51% |
| 2017-12-31 | CN¥1.52 Billion ≈ $222.22 Million |
+6.00% |
| 2016-12-31 | CN¥1.43 Billion ≈ $209.63 Million |
+9.49% |
| 2015-12-31 | CN¥1.31 Billion ≈ $191.46 Million |
+10.76% |
| 2014-12-31 | CN¥1.18 Billion ≈ $172.87 Million |
+8.34% |
| 2013-12-31 | CN¥1.09 Billion ≈ $159.56 Million |
+31.82% |
| 2012-12-31 | CN¥827.16 Million ≈ $121.04 Million |
+17.73% |
| 2011-12-31 | CN¥702.56 Million ≈ $102.81 Million |
+150.17% |
| 2010-12-31 | CN¥280.84 Million ≈ $41.10 Million |
+8.22% |
| 2009-12-31 | CN¥259.51 Million ≈ $37.97 Million |
+15.77% |
| 2008-12-31 | CN¥224.15 Million ≈ $32.80 Million |
-- |
About Shanxi C&Y Pharmaceutical Group Co Ltd
ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, smoking cessation drugs, pediatric drugs, respiratory system drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, nephropathy drugs, anti-depressant… Read more